• January 16, 2021

END THE LOCKDOWN: New Ioannidis Analysis of 12 Global Coronavirus Studies Finds 9 of 12 Show COVID-19 Fatality Rate Similar to Seasonal Flu

 END THE LOCKDOWN: New Ioannidis Analysis of 12 Global Coronavirus Studies Finds 9 of 12 Show COVID-19 Fatality Rate Similar to Seasonal Flu

Dr. John Ioannidis 

In April Stanford University researcher Dr. John Ioannidis presented a summary report from his recent coronavirus study in Santa Clara, California.

The research project looked at 3,300 people in Santa Clara County in California. The Stanford study revealed that 2.5% to 4.2% of people tested for COVID-19 were positive for antibodies.

The doctor’s data indicated that there are between 50 to 80-fold more infections in the general population than the confirmed cases.

This was a huge development.

In describing his findings Dr. Ioannidis concluded that the coronavirus has an infection fatality rate that is in the same ballpark as seasonal influenza.

Dr. Ioannidis added in April, “It suggests that even though this is a very serious problem, we should not fear. It suggests that we have solid ground to have optimism about the possibility of eventually opening our society and gaining back our lives.”

On Tuesday Dr. Ioannidis released a follow-up investigation on the coronavirus.

The abstract was published at medRxiv.

The new Ioannidis study reveals the infection fatality ratios (IFRs) of the Coronavirus from 12 seroprevalence studies of greater that 500 individuals per sample found:

7 of 12 studies saw a corrected IFR of 0.06-0.16, similar to seasonal flu

3 of 12 studies saw a modestly higher IFR of 0.25-0.40 – slightly higher than flu

2 of 12 studies saw a modestly lower IFR of 0.02-0.03 – slightly lower than flu

Here is a look at the sampled populations:

The new study shows the coronavirus has a similar mortality rate as the seasonal flu — according to Dr. Ioannidis.

Dr. Andrew Bostom wrote about this study earlier today.

Ioannidis’ analysis of covid19 infection fatality ratios (IFRs) from 12 seroprevalence

Source: The Gateway Pundit

cruznewslive

Leave a Reply

Your email address will not be published. Required fields are marked *

Pin It on Pinterest

Share This